• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清皮质醇作为慢性心力衰竭患者心脏事件的有用预测指标:氧化应激的影响

Serum cortisol as a useful predictor of cardiac events in patients with chronic heart failure: the impact of oxidative stress.

作者信息

Yamaji Masayuki, Tsutamoto Takayoshi, Kawahara Chiho, Nishiyama Keizo, Yamamoto Takashi, Fujii Masanori, Horie Minoru

机构信息

Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Tsukinowa, Seta, Otsu, Japan.

出版信息

Circ Heart Fail. 2009 Nov;2(6):608-15. doi: 10.1161/CIRCHEARTFAILURE.109.868513. Epub 2009 Sep 28.

DOI:10.1161/CIRCHEARTFAILURE.109.868513
PMID:19919986
Abstract

BACKGROUND

The pathophysiological role of cortisol, which binds to the mineralocorticoid receptor with an affinity equal to that of aldosterone (ALD), may be influenced by oxidative stress in patients with chronic heart failure. We evaluated cardiac event prediction using cortisol levels in chronic heart failure, in comparison with ALD, adrenocorticotropic hormone, and brain natriuretic peptide (BNP), and the impact of oxidative stress.

METHODS AND RESULTS

We measured the plasma levels of biomarkers such as BNP, ALD, adrenocorticotropic hormone, serum cortisol, and oxidized low-density lipoprotein (oxLDL), a biomarker of oxidative stress, in 319 consecutive symptomatic patients with chronic heart failure, and we followed these patients for a mean period of 33 months. During the follow-up period, 29 patients had cardiac events (death or hospitalization). Plasma levels of BNP, ALD, adrenocorticotropic hormone, oxLDL, and serum cortisol (16.8+/-1.8 microg/dL versus 12.4+/-0.3 microg/dL, P=0.01) were significantly higher in patients with cardiac events than in those without cardiac events. On stepwise multivariate analyses, high levels of BNP (P=0.0003), renin (P=0.002), cortisol (P=0.02), and oxLDL (P=0.002) were independent predictors of cardiac events, but ALD and adrenocorticotropic hormone levels were not. In patients with serum cortisol > or =12.5 microg/dL, the hazard ratio of cardiac events in patients with oxLDL > or =12 U/mL was 3.5 compared with that in patients with oxLDL <12 U/mL (P=0.008).

CONCLUSIONS

These findings indicate that serum cortisol levels were a complementary and incremental cardiac event risk predictor in combination with BNP in patients with chronic heart failure and that cardiac event prediction based on cortisol levels was influenced by oxidative stress.

摘要

背景

皮质醇与盐皮质激素受体的结合亲和力与醛固酮(ALD)相当,其病理生理作用可能受慢性心力衰竭患者氧化应激的影响。我们评估了慢性心力衰竭患者使用皮质醇水平预测心脏事件的情况,并与ALD、促肾上腺皮质激素和脑钠肽(BNP)进行比较,同时评估了氧化应激的影响。

方法和结果

我们测量了319例有症状的慢性心力衰竭连续患者的血浆生物标志物水平,如BNP、ALD、促肾上腺皮质激素、血清皮质醇和氧化应激生物标志物氧化型低密度脂蛋白(oxLDL),并对这些患者进行了平均33个月的随访。在随访期间,29例患者发生了心脏事件(死亡或住院)。发生心脏事件的患者血浆BNP、ALD、促肾上腺皮质激素、oxLDL和血清皮质醇水平(16.8±1.8μg/dL对12.4±0.3μg/dL,P=0.01)显著高于未发生心脏事件的患者。在逐步多变量分析中,高水平的BNP(P=0.0003)、肾素(P=0.002)、皮质醇(P=0.02)和oxLDL(P=0.002)是心脏事件的独立预测因素,但ALD和促肾上腺皮质激素水平不是。血清皮质醇≥12.5μg/dL的患者中,oxLDL≥12 U/mL的患者心脏事件风险比oxLDL<12 U/mL的患者高3.5倍(P=0.008)。

结论

这些发现表明,在慢性心力衰竭患者中,血清皮质醇水平与BNP联合是心脏事件风险的补充性和增量性预测指标,且基于皮质醇水平的心脏事件预测受氧化应激影响。

相似文献

1
Serum cortisol as a useful predictor of cardiac events in patients with chronic heart failure: the impact of oxidative stress.血清皮质醇作为慢性心力衰竭患者心脏事件的有用预测指标:氧化应激的影响
Circ Heart Fail. 2009 Nov;2(6):608-15. doi: 10.1161/CIRCHEARTFAILURE.109.868513. Epub 2009 Sep 28.
2
Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure.慢性心力衰竭中皮质醇和醛固酮对补充性和递增性死亡风险的预测作用
Circulation. 2007 Apr 3;115(13):1754-61. doi: 10.1161/CIRCULATIONAHA.106.653964. Epub 2007 Mar 19.
3
Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation.基线及6个月时B型利钠肽的变化是等待心脏移植的晚期心力衰竭患者发生事件的独立预测因素。
J Cardiovasc Med (Hagerstown). 2009 Sep;10(9):671-6. doi: 10.2459/JCM.0b013e328329346a.
4
B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.B型利钠肽指导治疗对亚重症监护病房急性心力衰竭住院患者预后的预测作用
J Card Fail. 2008 Apr;14(3):219-24. doi: 10.1016/j.cardfail.2007.10.009.
5
Antibodies to oxidized LDL as predictors of morbidity and mortality in patients with chronic heart failure.氧化型 LDL 抗体作为预测慢性心力衰竭患者发病率和死亡率的指标。
J Card Fail. 2009 Nov;15(9):770-4. doi: 10.1016/j.cardfail.2009.05.009. Epub 2009 Jul 3.
6
Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure.多标志物策略预测急性失代偿性慢性心力衰竭患者 31 天心脏死亡。
Int J Cardiol. 2010 Jun 11;141(3):284-90. doi: 10.1016/j.ijcard.2008.12.017. Epub 2009 Jan 20.
7
Association of low serum levels of apolipoprotein A-I with adverse outcomes in patients with nonischemic heart failure.非缺血性心力衰竭患者血清载脂蛋白A-I水平降低与不良预后的关联。
J Card Fail. 2007 May;13(4):247-53. doi: 10.1016/j.cardfail.2007.01.007.
8
Prognostic value of plasma renin activity in heart failure.血浆肾素活性对心力衰竭的预后价值。
Am J Cardiol. 2011 Jul 15;108(2):246-51. doi: 10.1016/j.amjcard.2011.03.034. Epub 2011 May 3.
9
Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.N末端脑钠肽前体在合并与未合并慢性肾脏病的心力衰竭患者中预后价值的比较
Am J Cardiol. 2008 Aug 15;102(4):469-74. doi: 10.1016/j.amjcard.2008.03.082. Epub 2008 May 24.
10
Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time.慢性心力衰竭门诊患者的系列生物标志物测量:随时间变化的重要性。
Circulation. 2007 Jul 17;116(3):249-57. doi: 10.1161/CIRCULATIONAHA.107.694562. Epub 2007 Jun 25.

引用本文的文献

1
[The functional role and properties of transcortin in the human body].[皮质素运载蛋白在人体中的功能作用及特性]
Probl Endokrinol (Mosk). 2024 Aug 1;70(6):27-34. doi: 10.14341/probl13482.
2
Salivary Cortisol Detection with a Fully Inkjet-Printed Paper-Based Electrochemical Sensor.基于全喷墨打印纸基电化学传感器的唾液皮质醇检测
Micromachines (Basel). 2024 Oct 12;15(10):1252. doi: 10.3390/mi15101252.
3
Targeting MuRF1 to Combat Skeletal Muscle Wasting in Cardiac Cachexia: Mechanisms and Therapeutic Prospects.靶向 MuRF1 防治心脏恶病质骨骼肌丢失:机制与治疗前景。
Med Sci Monit. 2024 Oct 22;30:e945211. doi: 10.12659/MSM.945211.
4
Linking hearts and minds: understanding the cardiovascular impact of bipolar disorder.连接心与脑:理解双相情感障碍的心血管影响。
Future Cardiol. 2024;20(13):709-718. doi: 10.1080/14796678.2024.2408944. Epub 2024 Oct 9.
5
Association of stress hormones and the risk of cardiovascular diseases systematic review and meta-analysis.应激激素与心血管疾病风险的关联:系统评价与荟萃分析
Int J Cardiol Cardiovasc Risk Prev. 2024 Jul 10;23:200305. doi: 10.1016/j.ijcrp.2024.200305. eCollection 2024 Dec.
6
Mechanistic insights into rumen function promotion through yeast culture () metabolites using and models.利用体外和体内模型对通过酵母培养物代谢产物促进瘤胃功能的作用机制的深入研究。
Front Microbiol. 2024 Jul 16;15:1407024. doi: 10.3389/fmicb.2024.1407024. eCollection 2024.
7
Glucocorticoids with or without fludrocortisone in septic shock: a narrative review from a biochemical and molecular perspective.糖皮质激素联合或不联合氟氢可的松治疗脓毒性休克:从生化和分子角度的叙述性综述。
Br J Anaesth. 2024 Jan;132(1):53-65. doi: 10.1016/j.bja.2023.10.034. Epub 2023 Nov 28.
8
Impact of a Stress Reduction, Meditation, and Mindfulness Program in Patients with Chronic Heart Failure: A Randomized Controlled Trial.减压、冥想和正念训练对慢性心力衰竭患者的影响:一项随机对照试验。
Arq Bras Cardiol. 2023 Oct;120(10):e20220768. doi: 10.36660/abc.20220768.
9
A Novel Cortisol Immunosensor Based on a Hafnium Oxide/Silicon Structure for Heart Failure Diagnosis.一种基于氧化铪/硅结构的用于心力衰竭诊断的新型皮质醇免疫传感器。
Micromachines (Basel). 2022 Dec 16;13(12):2235. doi: 10.3390/mi13122235.
10
A Novel Electrochemical Aptasensor Based on a New Platform of Samarium Molybdate Flower-like Nanoparticles@Poly(pyrrole) for Non-Invasive Determination of Saliva CORTISOL.基于钐钼酸盐花状纳米粒子@聚吡咯新型平台的新型电化学适体传感器用于非侵入式唾液皮质醇测定。
Biosensors (Basel). 2022 Sep 3;12(9):720. doi: 10.3390/bios12090720.